Dr. Einstein is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
330 Brookline Avenue
Boston, MA 02215Phone+1 617-667-2100
Education & Training
- Tufts Medical CenterResidency, Internal Medicine, 2011 - 2014
- Tufts University School of MedicineClass of 2011
- Yale UniversityB.S., Biology (Intensive), Neurobiology Track, 2003 - 2007
Certifications & Licensure
- MA State Medical License 2011 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Merit Award in Palliative Care Conquer Cancer Foundation of ASCO, 2014
- Excellence in Teaching Award Tufts University School of Medicine, 2014
- Notable Teaching Citation Tufts Medical Center Department of Medicine, 2013
- Join now to see all
Clinical Trials
- Nivolumab in Patients With High-Risk Biochemically Recurrent Prostate Cancer Start of enrollment: 2018 Oct 18
- Neratinib in Patients With Metastatic Castration-Resistant Prostate Cancer Start of enrollment: 2021 May 21
- Nivolumab + Docetaxel + ADT in mHSPC Patients With DDRD or Inflamed Tumors Start of enrollment: 2020 May 11
Roles: Principal Investigator, Contact
- Join now to see all
Publications & Presentations
PubMed
- Reply to B. Tombal et al.David J Einstein, Meredith M Regan, Julia S Stevens, David F McDermott, Ravi A Madan
Journal of Clinical Oncology. 2024-11-20 - 2 citationsA genetic basis for sex differences in Xp11 translocation renal cell carcinoma.Mingkee Achom, Ananthan Sadagopan, Chunyang Bao, Fiona McBride, Jiao Li
Cell. 2024-10-03 - 1 citationsAKT Inhibition Sensitizes to Polo-Like Kinase 1 Inhibitor Onvansertib in Prostate Cancer.Mannan Nouri, Andreas Varkaris, Maya Ridinger, Susan L Dalrymple, Christopher M Dennehy
Molecular Cancer Therapeutics. 2024-10-01
Journal Articles
- The ethical imperative of healthy paternalism in advance-directive discussions at the end of lifeEinstein DJ, Ladin K, and Mathew P, JAMA Oncol, 1/25/2016
- Dying for advice: code-status discussions between resident physicians patients with advanced cancer-a national surveyEinstein DJ, Einstein KL, and Mathew P, J Palliat Med, 1/1/2015
- A problematic palsy: an exercise in clinical reasoningEinstein DJ, Trowbridge RL, and Rencic J, J Gen Int Med, 1/1/2015
- Join now to see all
Abstracts/Posters
- "Expanded Prostate Cancer Index Composite-26 Online: Validation of an Internet-Based Instrument for Assessment of Health-Related Quality of Life after Treatment for Lo...Einstein DJ, American Urological Association Annual Meeting, San Diego, CA, 1/1/2016
- "Dying for advice: code-status discussions between resident physicians patients with advanced cancer-a national survey."Einstein DJ, ASCO Palliative Care in Oncology Symposium, Boston, MA, 1/1/2014
Press Mentions
- CAR-T Immunotherapy for Prostate Cancer?September 16th, 2024
- Cardiff Oncology Announces Updated Clinical and New Biomarker Data from Phase 2 Metastatic Castration-Resistant Prostate Cancer Trial at the AACR Annual MeetingApril 8th, 2022
- New Treatment Approved for Late-Stage Prostate CancerApril 7th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: